UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Nearly 45,000 left without power in Dagestan

Mullin highlights TRIPP corridor’s regional importance

El-Sayed sees path to ‘TrumpCare’ with Republican support

Trump warns of possible new strikes on Iran if talks fail

Russian investigators probe deadly family shooting in Yakutia

Belgian air traffic halted for 14 hours on Monday

Italian foreign minister arrives in Baku

Russian attack on supermarket kills one, injures three

Miley Cyrus marries Maxx Morando in California

19 suffer carbon monoxide poisoning at German church

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla